DK3596080T3 - Farmakologisk aktive alicyclisk-substitueret pyrazolo[1,5-a]pyrimidin-derivater - Google Patents

Farmakologisk aktive alicyclisk-substitueret pyrazolo[1,5-a]pyrimidin-derivater Download PDF

Info

Publication number
DK3596080T3
DK3596080T3 DK18713016.6T DK18713016T DK3596080T3 DK 3596080 T3 DK3596080 T3 DK 3596080T3 DK 18713016 T DK18713016 T DK 18713016T DK 3596080 T3 DK3596080 T3 DK 3596080T3
Authority
DK
Denmark
Prior art keywords
pyrimidine derivatives
pharmacological active
substituted pyrazolo
active alicyclic
alicyclic
Prior art date
Application number
DK18713016.6T
Other languages
Danish (da)
English (en)
Inventor
István Borza
János Éles
Zsuzsa Hadady
Viktor Román
Original Assignee
Richter Gedeon Nyrt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Nyrt filed Critical Richter Gedeon Nyrt
Application granted granted Critical
Publication of DK3596080T3 publication Critical patent/DK3596080T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14Ortho-condensed systems
    • C07D491/147Ortho-condensed systems the condensed system containing one ring with oxygen as ring hetero atom and two rings with nitrogen as ring hetero atom

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK18713016.6T 2017-03-13 2018-03-12 Farmakologisk aktive alicyclisk-substitueret pyrazolo[1,5-a]pyrimidin-derivater DK3596080T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU1700108A HU231058B1 (hu) 2017-03-13 2017-03-13 Gyógyászatilag hatékony aliciklusos-szubsztituált pirazolo[1,5-a]pirimidin származékok
PCT/IB2018/051599 WO2018167630A1 (en) 2017-03-13 2018-03-12 PHARMACOLOGICALLY ACTIVE ALICYCLIC-SUBSTITUTED PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVES

Publications (1)

Publication Number Publication Date
DK3596080T3 true DK3596080T3 (da) 2021-11-15

Family

ID=89992389

Family Applications (1)

Application Number Title Priority Date Filing Date
DK18713016.6T DK3596080T3 (da) 2017-03-13 2018-03-12 Farmakologisk aktive alicyclisk-substitueret pyrazolo[1,5-a]pyrimidin-derivater

Country Status (32)

Country Link
US (1) US11026946B2 (cg-RX-API-DMAC7.html)
EP (1) EP3596080B1 (cg-RX-API-DMAC7.html)
JP (1) JP7153662B2 (cg-RX-API-DMAC7.html)
KR (1) KR20190127779A (cg-RX-API-DMAC7.html)
CN (1) CN110431142A (cg-RX-API-DMAC7.html)
AR (1) AR111176A1 (cg-RX-API-DMAC7.html)
AU (1) AU2018235266B2 (cg-RX-API-DMAC7.html)
BR (1) BR112019018843A2 (cg-RX-API-DMAC7.html)
CA (1) CA3056185A1 (cg-RX-API-DMAC7.html)
CL (1) CL2019002601A1 (cg-RX-API-DMAC7.html)
CO (1) CO2019010120A2 (cg-RX-API-DMAC7.html)
CY (1) CY1124708T1 (cg-RX-API-DMAC7.html)
DK (1) DK3596080T3 (cg-RX-API-DMAC7.html)
EA (1) EA038756B1 (cg-RX-API-DMAC7.html)
EC (1) ECSP19072975A (cg-RX-API-DMAC7.html)
ES (1) ES2893824T3 (cg-RX-API-DMAC7.html)
GE (1) GEP20217256B (cg-RX-API-DMAC7.html)
HR (1) HRP20211850T1 (cg-RX-API-DMAC7.html)
HU (2) HU231058B1 (cg-RX-API-DMAC7.html)
IL (1) IL268923A (cg-RX-API-DMAC7.html)
LT (1) LT3596080T (cg-RX-API-DMAC7.html)
MX (1) MX2019011000A (cg-RX-API-DMAC7.html)
MY (1) MY195262A (cg-RX-API-DMAC7.html)
PE (1) PE20191646A1 (cg-RX-API-DMAC7.html)
PH (1) PH12019501968A1 (cg-RX-API-DMAC7.html)
PL (1) PL3596080T3 (cg-RX-API-DMAC7.html)
PT (1) PT3596080T (cg-RX-API-DMAC7.html)
RS (1) RS62533B1 (cg-RX-API-DMAC7.html)
SG (1) SG11201907864YA (cg-RX-API-DMAC7.html)
SI (1) SI3596080T1 (cg-RX-API-DMAC7.html)
UA (1) UA124783C2 (cg-RX-API-DMAC7.html)
WO (1) WO2018167630A1 (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20241558T1 (hr) 2017-03-13 2025-03-28 Lundbeck La Jolla Research Center, Inc. Dvojni inhibitori magl i faah
HU231057B1 (hu) 2017-03-13 2020-04-28 Richter Gedeon Nyrt Gyógyászatilag hatékony aril-szubsztituált pirazolo[1,5-a]pirimidin származékok
JP2023520647A (ja) 2020-03-26 2023-05-18 リヒター ゲデオン ニュイルヴァーノシャン ミューコェデー レースヴェーニュタールシャシャーグ GABA Aアルファ5受容体調節剤としてのナフチリジンおよびピリド[3,4-c]ピリダジン誘導体
CN120590392A (zh) 2020-08-05 2025-09-05 吉瑞工厂 药理学活性的杂环取代的吡唑并[1,5-a]嘧啶衍生物
HU231691B1 (hu) 2021-09-29 2025-10-28 Richter Gedeon Nyrt GABAA ALFA5 receptor modulátor hatású biciklusos aminszármazékok
CN115872095A (zh) * 2022-11-28 2023-03-31 南通三鑫车灯配件有限公司 一种汽车车灯反光罩的生产线流转装置

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2557719A1 (en) 2004-03-02 2005-10-13 F. Hoffmann-La Roche Ag 4- (sulfanyl-pyrimidin-4-ylmethyl) -morpholine derivatives and related compounds as gaba receptor ligands for the treatment of anxiety, depression and epilepsy
GB0512844D0 (en) 2005-06-23 2005-08-03 Novartis Ag Organic compounds
KR100753017B1 (ko) 2006-05-25 2007-08-30 한국화학연구원 7-(3,4-디알콕시페닐)-피라졸로[1,5-a]피리미딘 화합물을포함하는 관절염, 아토피 피부염, 백혈병을 포함한 암 및알쯔하이머, 우울증 또는 기억력 감소 등의 뇌질환의 치료및 예방을 위한 약제학적 조성물
US8461163B2 (en) 2008-03-31 2013-06-11 Takeda Pharmaceutical Company Limited Substituted N-(pyrazolo[1,5-a]pyrimidin-5-yl)amides as inhibitors of apoptosis signal-regulating kinase 1
TWI648281B (zh) 2013-10-17 2019-01-21 日商安斯泰來製藥股份有限公司 含硫二環式化合物
EP3286192A1 (en) 2015-04-20 2018-02-28 AbbVie Deutschland GmbH & Co KG Substituted pyrazolopyrimidines and method of use
JP2018199623A (ja) 2015-10-22 2018-12-20 大正製薬株式会社 含窒素縮合複素環化合物
HU231057B1 (hu) 2017-03-13 2020-04-28 Richter Gedeon Nyrt Gyógyászatilag hatékony aril-szubsztituált pirazolo[1,5-a]pirimidin származékok

Also Published As

Publication number Publication date
HUP1700108A2 (en) 2018-09-28
WO2018167630A1 (en) 2018-09-20
US11026946B2 (en) 2021-06-08
CY1124708T1 (el) 2022-07-22
RS62533B1 (sr) 2021-11-30
HUE056562T2 (hu) 2022-02-28
MY195262A (en) 2023-01-11
CO2019010120A2 (es) 2019-10-09
CA3056185A1 (en) 2018-09-20
EA038756B1 (ru) 2021-10-14
AR111176A1 (es) 2019-06-12
PH12019501968A1 (en) 2020-06-29
PT3596080T (pt) 2021-10-22
PE20191646A1 (es) 2019-11-07
UA124783C2 (uk) 2021-11-17
AU2018235266A1 (en) 2019-10-17
SI3596080T1 (sl) 2022-01-31
HU231058B1 (hu) 2020-04-28
EA201992127A1 (ru) 2020-02-06
CL2019002601A1 (es) 2020-01-24
US20200129515A1 (en) 2020-04-30
KR20190127779A (ko) 2019-11-13
HRP20211850T1 (hr) 2022-03-04
LT3596080T (lt) 2021-11-25
EP3596080B1 (en) 2021-09-01
MX2019011000A (es) 2019-10-17
EP3596080A1 (en) 2020-01-22
BR112019018843A2 (pt) 2020-04-14
ES2893824T3 (es) 2022-02-10
PL3596080T3 (pl) 2022-01-31
JP7153662B2 (ja) 2022-10-14
SG11201907864YA (en) 2019-09-27
AU2018235266B2 (en) 2021-09-30
IL268923A (en) 2019-10-31
GEP20217256B (en) 2021-05-25
JP2020510041A (ja) 2020-04-02
ECSP19072975A (es) 2019-11-30
CN110431142A (zh) 2019-11-08

Similar Documents

Publication Publication Date Title
DK3596080T3 (da) Farmakologisk aktive alicyclisk-substitueret pyrazolo[1,5-a]pyrimidin-derivater
IL260923B (en) History of pyrazolo[5,1-a]pyrazin-4-yl as jak inhibitors
DK3478682T3 (da) [1,2,4]triazolo[1,5-a]pyridinylsubstituerede indolforbindelser
HUE055201T2 (hu) Triazolo[4,5-D]pirimidin-származékok mint CBB2-receptor-antagonisták
EP3268000A4 (en) Pyrazolo[1,5-a][1,3,5]triazine and pyrazolo[1,5-a]pyrimidine derivatives as cdk inhibitors
IL254224A0 (en) 7-substituted 5-alkyl-[4,2,1]triazolo[5,1-a]pyrimidine derivatives as pde2 inhibitors
HUE057549T2 (hu) Imidazo[1,2-a]pirimidinszármazékok, eljárás elõállításukra és alkalmazásaik
EP3744723A4 (en) SUBSTITUTED MACROCYCLIC PYRAZOLO [1,5-A] PYRIMIDINE COMPOUND
IL262673A (en) A pyrazolo[5,1-a]pyrimidine compound
HUE043291T2 (hu) 7-benzil-4-(2-metilbenzil)-2,4,6,7,8,9-hexahidroimidazo[1,2-a] pirido[3,4-e]pirimidin-5(lH)-on, sói és alkalmazási eljárások
IL290419A (en) Imidazo[a-1,5]pyrazine derivatives as inhibitors of pi3k delta
EP3546458A4 (en) PYRIDO [3,4-D] PYRIMIDINE DERIVATIVE AND PHARMACEUTICAL ACCEPTABLE SALT THEREOF
HUE056561T2 (hu) Gyógyászatilag hatékony aril-szubsztituált pirazolo[1,5-a]pirimidin származékok
DK3679042T3 (da) Imidazo[1,5-A]pyrazin-derivater som PI3Kdelta-inhibitorer
HRP20182021T1 (hr) Derivati [1,2,4]triazolo[1,5-a]pirimidina kao inhibitori proteazoma protozoe za liječenje parazitskih bolesti poput lišmenijaze
EP3590516A4 (en) ANTI-TUMOR ACTIVATOR USING A PYRAZOLO [3,4-D] PYRIMIDINE COMPOUND
EP3903788A4 (en) PYRAZOLO[1,5-A] PYRIMIDINE MACROCYCLIC COMPOUND
HUE052997T2 (hu) JAK kináz inhibitor pirazol[1,5-a]pirimidin származékok
EP3727379A4 (en) SALT OF PYRAZOLO [1,5-A] PYRIDINE DERIVATIVES AND USES
TH1601001194A (th) อนุพันธ์ไตรอะโซโล[4,5-d]ไพริมิดีน ใหม่